Hjem › Lungecancer › Oregon › Eugene
Lungecancer kliniske forsøg i Eugene, OR
5 studier for Lungecancer søger deltagere på steder i og omkring Eugene (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
RekruttererFase 3
- Oncology Associates of Oregon PC, Eugene
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- USO - Oncology Associates of Oregon, Eugene
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
RekruttererFase 1
- USOR - Oncology Associates of Oregon, P.C, Eugene
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
RekruttererFase 1
- Willamette Valley Cancer Institute and Research Center, Eugene
MYLUNG Consortium Part 3: Observational Study
RekruttererObservationsstudie
- Willamette Valley Cancer Institute and Research Center, Eugene
Lungecancer forsøg i andre byer
- Houston, TX78 studier
- Boston, MA62 studier
- New York City, NY60 studier
- Los Angeles, CA45 studier
- Washington, DC41 studier
- Arlington, VA41 studier
- Chicago, IL41 studier
- Nashville, TN40 studier
- Baltimore, MD40 studier
- St. Louis, MO39 studier
- Columbus, OH37 studier
- Philadelphia, PA36 studier
Andre studier i Eugene
- Ikke-småcellet lungecancer13 studier
- Ægstockræft9 studier
- Livmoderslimhindekræft8 studier
- Brystkræft7 studier
- Kronisk lymfatisk leukæmi6 studier
- Multipelt myelom6 studier
- Metastatisk cancer6 studier
- Kræft (alle typer)6 studier
- Stofbrug og afhængighed5 studier
- Makuladegeneration5 studier
- Overvægt4 studier
- Prostatakræft3 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.